Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lgnd crawled date : 2022 - 10 - 26 save search
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
VKTX | $64.7 -2.66% -2.74% 2.4M
|
Health Technology
|
| O: -2.2%
H: 12.5%
C: 3.75%
LGND | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
therapeutics financial update results
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-26 (Crawled : 12:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AHPA 4 | $6.125 -9.26% 4.33%
|
|
| O: -5.1%
H: 1.72%
C: -8.48%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
LGND | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
treatment fda approval
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.